Cargando…

A Modified Method to Isolate Circulating Tumor Cells and Identify by a Panel of Gene Mutations in Lung Cancer

The CellSearch system is the only FDA approved and successful used detection technology for circulating tumor cells(CTCs). However, the process for identification of CTCs by CellSearch appear to damage the cells, which may adversely affects subsequent molecular biology assays. We aimed to explore an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Helin, Wu, Jieqing, Zhang, Qi, Hao, Jianqing, Wang, Ying, Li, Zhuoran, Niu, Hongrui, Zhang, Hongtao, Zhang, Shucai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155778/ https://www.ncbi.nlm.nih.gov/pubmed/34032165 http://dx.doi.org/10.1177/1533033821995275

Ejemplares similares

Isolation of circulating tumor cells and detection of EGFR mutations in patients with non-small-cell lung cancer
por: Zhang, Qi, et al.
Publicado: (2019)

CD137 ligand feedback upregulates PD‐L1 expression on lung cancer via T cell production of IFN‐γ
por: Wang, Helin, et al.
Publicado: (2019)

Heterogeneous mutation pattern in tumor tissue and circulating tumor DNA warrants parallel NGS panel testing
por: Guo, Qiaomei, et al.
Publicado: (2018)

Circulating EGFR Mutations in Patients with Lung Adenocarcinoma by Circulating Tumor Cell Isolation Systems: A Concordance Study
por: Li, Shih-Hong, et al.
Publicado: (2022)

Multi-Biomarkers Panel in Identifying Benign and Malignant Lung Diseases and Pathological Types of Lung Cancer
por: Yao, Lige, et al.
Publicado: (2023)

Identification of a small mutation panel of coding sequences to predict the efficacy of immunotherapy for lung adenocarcinoma
por: Li, Ying, et al.
Publicado: (2020)

A novel mutation panel for predicting etoposide resistance in small-cell lung cancer
por: Qiu, Zhengang, et al.
Publicado: (2019)

An Ophthalmic Targeted Exome Sequencing Panel as a Powerful Tool to Identify Causative Mutations in Patients Suspected of Hereditary Eye Diseases
por: Wang, Panfeng, et al.
Publicado: (2019)

Designing gene panels for tumor mutational burden estimation: the need to shift from ‘correlation’ to ‘accuracy’
por: Wu, Hao-Xiang, et al.
Publicado: (2019)

Epidermal growth factor receptor‐tyrosine kinase inhibitor therapy is especially beneficial to patients with exon 19 deletion compared with exon 21 L858R mutation in non‐small‐cell lung cancer: Systematic review and meta analysis
por: Liu, Yinghui, et al.
Publicado: (2016)

Evaluation of Detection Methods and Values of Circulating Vascular Endothelial Growth Factor in Lung Cancer
por: Guo, Sumin, et al.
Publicado: (2018)

Validity of an NGS-based multiple gene panel in identifying actionable mutations for patients with NSCLC in a Chinese hospital
por: Cao, Wei, et al.
Publicado: (2019)

Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer
por: Duan, Weili, et al.
Publicado: (2016)

Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels
por: LaDuca, Holly, et al.
Publicado: (2017)

Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer
por: Villaflor, Victoria, et al.
Publicado: (2016)

A Novel PCCA Mutation in a Patient With Late-Onset Propionic Acidemia Identified by Genetic Diagnosis Panel
por: Wang, Yanyun, et al.
Publicado: (2018)

Development of an HIV-1 Subtype Panel in China: Isolation and Characterization of 30 HIV-1 Primary Strains Circulating in China
por: Han, Jingwan, et al.
Publicado: (2015)

The Value of Circulating Tumor Cells and Tumor Markers Detection in Lung Cancer Diagnosis
por: Guo, Sumin, et al.
Publicado: (2023)

Key pathways in prostate cancer with SPOP mutation identified by bioinformatic analysis
por: Ding, Guanxiong, et al.
Publicado: (2020)

Next-generation sequencing identifies pathogenic and modifier mutations in a consanguineous Chinese family with hypertrophic cardiomyopathy
por: Zhang, Xinlin, et al.
Publicado: (2017)

PCSK9 regulates the efficacy of immune checkpoint therapy in lung cancer
por: Gao, Xiang, et al.
Publicado: (2023)

Circulating MicroRNA Panel as a Diagnostic Marker for Hepatocellular Carcinoma
por: Wu, Xiaochang, et al.
Publicado: (2022)

A Modified Extraction Method of Circulating Free DNA for Epidermal Growth Factor Receptor Mutation Analysis
por: Yuan, Haihua, et al.
Publicado: (2012)

Clinicopathological characteristics and outcomes of ROS1-rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK rearrangements
por: Wu, Shafei, et al.
Publicado: (2015)

Multigene panel analysis identified germline mutations of DNA repair genes in breast and ovarian cancer
por: Hirotsu, Yosuke, et al.
Publicado: (2015)

Clinical Multigene Panel Sequencing Identifies Distinct Mutational Association Patterns in Metastatic Colorectal Cancer
por: Belardinilli, Francesca, et al.
Publicado: (2020)

Impacts of mutation effects and population size on mutation rate in asexual populations: a simulation study
por: Jiang, Xiaoqian, et al.
Publicado: (2010)

Quantitative proteomics identified circulating biomarkers in lung adenocarcinoma diagnosis
por: Chen, Hongyu, et al.
Publicado: (2022)

A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis
por: Zhou, Xin, et al.
Publicado: (2016)

HER2 Exon 20 Insertion Mutations in Lung Adenocarcinoma: Case Series and Response to Pyrotinib
por: Zhang, Xinyong, et al.
Publicado: (2020)

Proteomics and metabolomics profiling reveal panels of circulating diagnostic biomarkers and molecular subtypes in stable COPD
por: Zhang, Zili, et al.
Publicado: (2023)

Gene Mutation Analysis in Papillary Thyroid Carcinoma Using a Multi-Gene Panel in China
por: Wang, Qiang, et al.
Publicado: (2021)

Circulating cell‐free circRNA panel predicted tumorigenesis and development of colorectal cancer
por: Qi, Le, et al.
Publicado: (2022)

Mechanisms of resistance to irreversible epidermal growth factor receptor tyrosine kinase inhibitors and therapeutic strategies in non-small cell lung cancer
por: Xu, Jing, et al.
Publicado: (2017)

Next-Generation Sequencing Panel Analysis of Clinically Relevant Mutations in Circulating Cell-Free DNA from Patients with Gestational Trophoblastic Neoplasia: A Pilot Study
por: Luo, Lingxiao, et al.
Publicado: (2020)

Integration of circulating tumor cell and neutrophil-lymphocyte ratio to identify high-risk metastatic castration-resistant prostate cancer patients
por: Chong, Weelic, et al.
Publicado: (2021)

Evaluation of a novel approach to circulating tumor cell isolation for cancer gene panel analysis in patients with breast cancer
por: Lee, Soo Jeong, et al.
Publicado: (2017)

Serum biomarker panels for the diagnosis of gastric cancer
por: Wu, Dan, et al.
Publicado: (2019)

Integrated characterisation of cancer genes identifies key molecular biomarkers in stomach adenocarcinoma
por: Wang, Haifeng, et al.
Publicado: (2020)

A Mononucleotide Markers Panel to Identify hMLH1/hMSH2 Germline Mutations
por: Pedroni, M., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_8oos9ne1m8vdrd1aivtaqr5sjc